Nucleophilic aromatic substitutions enable diversity-oriented synthesis of heterocyclic atropisomers via non-atropisomeric intermediates
Open Access
- 25 May 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Abstract
Atropisomers are sterically hindered molecules whose formation typically proceeds via atropisomeric intermediates and encumbered transition states. It is therefore largely accepted that the activation energy is higher for synthesis of atropisomers than for synthesis of similar, less sterically congested non-atropisomeric compounds. Here we show that atropisomer formation by nucleophilic aromatic substitution (SNAr) reactions can progress via non-atropisomeric intermediates and transition states. We put forth fast, mild, practical, regio- and chemoselective SNAr reactions that generate a diverse array of difficult-to-access heterobiaryl C─N atropisomers starting with readily available N─H heterocycles and aryl fluorides, as well as two catalytic methods employing N─SiR3 and N─H heterocycles for synthesis of title atropisomers in seconds. Products of SNAr are readily diversifiable, streamlining access to countless drug-like C─N atropisomers, including macrocycles, peptides, and analogs of achiral heterobiaryl pharmaceuticals. Supported by experimental and computational data, we discuss how steric repulsion is minimized in stereogenic axis-forming SNAr processes.Keywords
This publication has 48 references indexed in Scilit:
- Trifluoromethyltrimethylsilane: Nucleophilic Trifluoromethylation and BeyondChemical Reviews, 2014
- Evolution of Catalytic Stereoselective Olefin Metathesis: From Ancillary Transformation to Purveyor of Stereochemical IdentityThe Journal of Organic Chemistry, 2014
- Axially Chiral Macrocyclic E-Alkene Bearing Bisazole Component Formed by Sequential C–H Homocoupling and Ring-Closing MetathesisOrganic Letters, 2012
- Assessing Atropisomer Axial Chirality in Drug Discovery and DevelopmentJournal of Medicinal Chemistry, 2011
- Route to three-dimensional fragments using diversity-oriented synthesisProceedings of the National Academy of Sciences, 2011
- Atroposelective Total Synthesis of Axially Chiral Biaryl Natural ProductsChemical Reviews, 2010
- AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABLBritish Journal of Cancer, 2006
- Stereoselective Synthesis of Axially Chiral N−C Bonds in N-Aryl IndolesOrganic Letters, 2006
- Target-Oriented and Diversity-Oriented Organic Synthesis in Drug DiscoveryScience, 2000
- Monotherapy with Nilutamide, A Pure Nonsteroidal Antiandrogen, in Untreated Patients with Metastatic Carcinoma of the ProstateJournal of Urology, 1991